130 related articles for article (PubMed ID: 11104393)
1. Statistical perspective on adjusting for center effect in a 2 x 2 crossover design with application to clinical trials.
Yue LQ
J Biopharm Stat; 2000 Nov; 10(4):559-71. PubMed ID: 11104393
[TBL] [Abstract][Full Text] [Related]
2. The analysis of incomplete data in the three-period two-treatment cross-over design for clinical trials.
Richardson BA; Flack VF
Stat Med; 1996 Jan; 15(2):127-43. PubMed ID: 8614750
[TBL] [Abstract][Full Text] [Related]
3. A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials.
Yue LQ; Roach P
J Biopharm Stat; 1998 Nov; 8(4):577-84. PubMed ID: 9855035
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headache.
Koch GG; Amara IA; MacMillan J
J Biopharm Stat; 1994 Nov; 4(3):347-410. PubMed ID: 7881452
[TBL] [Abstract][Full Text] [Related]
5. A comment on interim analyses in crossover trials.
Grieve AP; Senn S
Biometrics; 1996 Dec; 52(4):1515-20. PubMed ID: 9019232
[TBL] [Abstract][Full Text] [Related]
6. Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.
Dawson JD; Han SH
J Biopharm Stat; 2000 Nov; 10(4):447-55. PubMed ID: 11104386
[TBL] [Abstract][Full Text] [Related]
7. Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies.
Parienti JJ; Kuss O
Contemp Clin Trials; 2007 May; 28(3):316-23. PubMed ID: 17110172
[TBL] [Abstract][Full Text] [Related]
8. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
Siddiqui O; Hung HM; O'Neill R
J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
[TBL] [Abstract][Full Text] [Related]
9. Estimating treatment effects in clinical crossover trials.
Grieve A; Senn S
J Biopharm Stat; 1998 May; 8(2):191-233; discussion 235-47. PubMed ID: 9598420
[TBL] [Abstract][Full Text] [Related]
10. An alternative analysis for crossover studies that accounts for between-group disparities in drug response.
Cleophas TJ
Int J Clin Pharmacol Ther; 1997 Nov; 35(11):504-8. PubMed ID: 9401831
[TBL] [Abstract][Full Text] [Related]
11. Effect of dropouts in a longitudinal study: an application of a repeated ordinal model.
Lesaffre E; Molenberghs G; Dewulf L
Stat Med; 1996 Jun; 15(11):1123-41. PubMed ID: 8804143
[TBL] [Abstract][Full Text] [Related]
12. Tests for the analysis of variance of crossover designs with correlated errors.
Bellavance F; Tardif S; Stephens MA
Biometrics; 1996 Jun; 52(2):607-12. PubMed ID: 8672705
[TBL] [Abstract][Full Text] [Related]
13. Adaptive covariate adjustment in clinical trials.
Wang SJ; Hung HM
J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
[TBL] [Abstract][Full Text] [Related]
14. Detecting qualitative interactions in clinical trials: an extension of range test.
Li J; Chan IS
J Biopharm Stat; 2006; 16(6):831-41. PubMed ID: 17146982
[TBL] [Abstract][Full Text] [Related]
15. Statistical methods for active extension trials.
Hu Z; Follmann D
Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
[TBL] [Abstract][Full Text] [Related]
16. The use of baseline covariates in crossover studies.
Kenward MG; Roger JH
Biostatistics; 2010 Jan; 11(1):1-17. PubMed ID: 19915170
[TBL] [Abstract][Full Text] [Related]
17. Sample size calculation for cluster randomized cross-over trials.
Giraudeau B; Ravaud P; Donner A
Stat Med; 2008 Nov; 27(27):5578-85. PubMed ID: 18646266
[TBL] [Abstract][Full Text] [Related]
18. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
19. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
20. Robust procedures for analysing a two-period cross-over design with baseline measurements.
Tsai KT; Patel HL
Stat Med; 1996 Jan; 15(2):117-26. PubMed ID: 8614749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
